Met Life Investment Management, LLC Standard Biotools Inc. Transaction History
Met Life Investment Management, LLC
- $20.1 Billion
- Q3 2025
A detailed history of Met Life Investment Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 152,929 shares of LAB stock, worth $189,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152,929
Previous 181,262
15.63%
Holding current value
$189,631
Previous $217,000
8.76%
% of portfolio
0.0%
Previous 0.0%
Shares
43 transactions
Others Institutions Holding LAB
# of Institutions
164Shares Held
284MCall Options Held
59.7KPut Options Held
18.7K-
Casdin Capital, LLC New York, NY77.6MShares$96.2 Million13.74% of portfolio
-
Viking Global Investors LP58.7MShares$72.7 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$21.4 Million0.0% of portfolio
-
Mak Capital One LLC New York, NY15.9MShares$19.8 Million3.18% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $97.5M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...